Can extra cholesterol-lowering help after a stent?
Part of Heart & circulation clinical trials.
This trial looks at whether stronger cholesterol-lowering medicine can reduce the risk of future heart problems in people who already have a stent. It focuses on people who still have other mildly narrowed spots in their arteries.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have heart disease and have had a successful stent placement (angioplasty) to open a blocked artery.
- You have other narrowed areas (20–50% blocked) near the stent that can be clearly seen on an angiogram (X-ray of your arteries).
- Your age is between 18 and 75.
- You do not have an autoimmune disease or take immune-suppressing drugs.
- You do not have a genetic condition called familial hypercholesterolemia (very high inherited cholesterol).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a powerful cholesterol-lowering drug (PCSK9 inhibitor) very early after a heart attack can help prevent further heart problems. It is for people who have had a recent heart attack and have blockages in more than one heart artery.
This trial compares different LDL cholesterol targets to find the best level for people at very high risk after a heart stent procedure. It tests whether aiming for a lower cholesterol goal improves outcomes.
This trial compares two ways of guiding cholesterol-lowering treatment in people who have had a heart stent placed. It aims to find which method helps lower heart risks more effectively.
This trial tests whether a single dose of a cholesterol-lowering drug called a PCSK9 inhibitor can improve heart outcomes after a stent procedure. If you recently had a stent and the imaging showed significant plaque, this may help reduce future risks.
This study compares different combinations of antiplatelet (blood-thinning for the stent) and cholesterol-lowering (statin) medicines after stent placement for a heart attack or unstable angina. The goal is to find the best way to prevent future heart problems and improve outcomes.
This trial tests different blood thinner medicines after a heart stent is placed. It aims to find the best way to prevent blood clots while reducing bleeding risk.
Hear when a new Coronary Heart Disease (CHD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.